Výsledky vyhledávání - "Allan D, Sniderman"

Akademický článek

Autor: Ciaran Kohli-Lynch, PhD, George Thanassoulis, MD, Michael Pencina, PhD, Daniel Sehayek, MD, Karol Pencina, PhD, Andrew Moran, MD, MPH, Allan D. Sniderman, MD

Publikováno v: JACC: Advances, Vol 3, Iss 9, Pp 101090- (2024)

Externí odkaz: https://doaj.org/article/41c8ef164fc248c493d446e449858d9f

Zobrazit plný text záznamu

Akademický článek

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol

Autor: John H. Contois, Michel R. Langlois, Christa Cobbaert, Allan D. Sniderman

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 15 (2023)

ABSTRACT Concern continues about whether the measurement of apolipoprotein B (apoB) is adequately standardized, and therefore, whether apoB should be applied widely in clinical care. This concern is misplaced. Our objective is to explain why and what

Externí odkaz: https://doaj.org/article/27639cdab59d49298ed7e22352c56b8b

Zobrazit plný text záznamu

Akademický článek

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

Autor: Tamara Glavinovic, George Thanassoulis, Jacqueline de Graaf, Patrick Couture, Robert A. Hegele, Allan D. Sniderman

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 20 (2022)

In 2019, the European Society of Cardiology/European Atherosclerosis Society stated that apolipoprotein B (apoB) was a more accurate marker of cardiovascular risk than low‐density lipoprotein cholesterol (LDL‐C) and non–high‐density lipoprote

Externí odkaz: https://doaj.org/article/664a0cf2887d4ac89eca4640854b2a1e

Zobrazit plný text záznamu

Akademický článek

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study

Autor: Mehdi Afshar, Jian Rong, Yang Zhan, Hao Yu Chen, James C. Engert, Allan D. Sniderman, Martin G. Larson, Ramachandran S. Vasan, George Thanassoulis

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 18 (2020)

Background Elevated lipoprotein(a) is a well‐established risk factor for atherosclerotic vascular disease but is not measured in routine clinical care. Screening of high lipoprotein(a) in individuals with moderate elevations of low‐density lipopr

Externí odkaz: https://doaj.org/article/78cff3de46e64c2181b6a75f0bf829ae

Zobrazit plný text záznamu

Akademický článek

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding

Autor: Allan D. Sniderman, Patrick Couture, Seth S. Martin, Jacqueline DeGraaf, Patrick R. Lawler, William C. Cromwell, John T. Wilkins, George Thanassoulis

Publikováno v: Journal of Lipid Research, Vol 59, Iss 7, Pp 1266-1275 (2018)

Triglycerides are the conventional tool to measure VLDLs, whereas LDL cholesterol (LDL-C) is the conventional tool to measure LDLs. Multiple epidemiological studies, including a series of genetically based analyses, have demonstrated that cardiovascu

Externí odkaz: https://doaj.org/article/231a2c28405b4fd9b3571bbc58853449

Zobrazit plný text záznamu

Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart Disease

Autor: Karol M Pencina, Michael J Pencina, Patrick R Lawler, James C Engert, Line Dufresne, Paul M Ridker, George Thanassoulis, Samia Mora, Allan D Sniderman

Publikováno v: Clinical Chemistry. 69:48-55

Background We examined the interplay of apolipoprotein B (apoB) and LDL particle size, approximated by the LDL-cholesterol (LDL-C)/apoB ratio, on the risk of new-onset coronary heart disease (CHD). Methods Participants without cardiovascular disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb89a5be8f30616be33213e646af180
https://doi.org/10.1093/clinchem/hvac172

Zobrazit plný text záznamu

An adverse lipoprotein phenotype—hypertriglyceridaemic hyperapolipoprotein B—and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study

Autor: Karol M, Pencina, Michael J, Pencina, Line, Dufresne, Michael, Holmes, George, Thanassoulis, Allan D, Sniderman

Publikováno v: The Lancet Healthy Longevity. 3:e339-e346

This study examines the risk of new-onset diabetes in patients with hypertriglyceridaemic hyperapolipoprotein B (high triglycerides, high apolipoprotein B [apoB], low LDL cholesterol to apoB ratio, and low HDL cholesterol). The aim was to establish w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f47d2edf071bce55be176be560da39c
https://doi.org/10.1016/s2666-7568(22)00079-4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání